These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 25632071)

  • 21. Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study.
    ; Bohlius J; Schmidlin K; Costagliola D; Fätkenheuer G; May M; Caro-Murillo AM; Mocroft A; Bonnet F; Clifford G; Karafoulidou A; Miro JM; Lundgren J; Chene G; Egger M
    Antivir Ther; 2009; 14(8):1065-74. PubMed ID: 20032536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant lymphoma in the HIV-positive patient.
    Meister A; Hentrich M; Wyen C; Hübel K
    Eur J Haematol; 2018 Jul; 101(1):119-126. PubMed ID: 29663523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-Hodgkin's lymphoma as a rare manifestation of immune reconstitution disease in HIV-1 positive patients.
    Knysz B; Kuliszkiewicz-Janus M; Jeleń M; Podlasin R; Gładysz A
    Postepy Hig Med Dosw (Online); 2006; 60():547-51. PubMed ID: 17060896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short communication: spectrum of non-Hodgkin lymphoma in an urban Ryan White-funded clinic in the established antiretroviral era.
    Silverton A; Gunthel C; Adamski M; Mosunjac M; Nguyen ML
    AIDS Res Hum Retroviruses; 2014 Jul; 30(7):665-9. PubMed ID: 24707838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changing incidence and survival in patients with aids-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART).
    Chow KU; Mitrou PS; Geduldig K; Helm EB; Hoelzer D; Brodt HR
    Leuk Lymphoma; 2001 Mar; 41(1-2):105-16. PubMed ID: 11342362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic variables and 4-year survival outcomes in CD20 Positive AIDS-Related Lymphoma in the Anti-retroviral treatment era: A Retrospective Review from a Single Centre in KwaZulu-Natal, South Africa.
    Rapiti N; Abdelatif N; Moosa MS
    PLoS One; 2022; 17(9):e0272282. PubMed ID: 36048870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma.
    Tam HK; Zhang ZF; Jacobson LP; Margolick JB; Chmiel JS; Rinaldo C; Detels R
    Int J Cancer; 2002 Apr; 98(6):916-22. PubMed ID: 11948473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-associated non-Hodgkin's lymphoma: experience from a regional cancer center.
    Sharma A; Bajpai J; Raina V; Mohanti BK
    Indian J Cancer; 2010; 47(1):35-9. PubMed ID: 20071788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement of systemic human immunodeficiency virus-related non-Hodgkin lymphoma outcome in the era of highly active antiretroviral therapy.
    Vaccher E; Spina M; Talamini R; Zanetti M; di Gennaro G; Nasti G; Tavio M; Bernardi D; Simonelli C; Tirelli U
    Clin Infect Dis; 2003 Dec; 37(11):1556-64. PubMed ID: 14614680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
    Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM
    J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival among patients with primary central nervous system lymphoma, 1973-2004.
    Norden AD; Drappatz J; Wen PY; Claus EB
    J Neurooncol; 2011 Feb; 101(3):487-93. PubMed ID: 20556477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-Hodgkin's lymphoma among patients infected with human immunodeficiency virus: the experience of a single center in Brazil.
    Tanaka PY; Pracchia LF; Calore EE
    Int J Hematol; 2006 Nov; 84(4):337-42. PubMed ID: 17118760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical characteristics, pathological distribution, and prognostic factors in non-Hodgkin lymphoma of Waldeyer's ring: nationwide Korean study.
    Lee SJ; Suh CW; Lee SI; Kim WS; Lee WS; Kim HJ; Choi CW; Kim JS; Shin HJ;
    Korean J Intern Med; 2014 May; 29(3):352-60. PubMed ID: 24851070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Primary extralymphatic non-Hodgkin's lymphomas: the response to treatment and prognostic factors in 73 patients].
    Oriol A; Ribera JM; Flores A; Batlle M; las Heras G; Vaquero M; Juncá J; Millá F; Feliu E
    Med Clin (Barc); 1995 Mar; 104(8):281-6. PubMed ID: 7700086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feasibility and Efficacy of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation for HIV-Associated Lymphoma: A Single-Institution Experience.
    Ayala E; Chavez JC; Gomez A; Sleiman E; Kumar A; Kharfan-Dabaja MA
    Clin Lymphoma Myeloma Leuk; 2018 Aug; 18(8):548-551. PubMed ID: 29937399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy.
    Achenbach CJ; Cole SR; Kitahata MM; Casper C; Willig JH; Mugavero MJ; Saag MS
    AIDS; 2011 Mar; 25(5):691-700. PubMed ID: 21160411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical features and prognosis of 100 AIDS-related lymphoma cases.
    Wu D; Chen C; Zhang M; Li Z; Wang S; Shi J; Zhang Y; Yao D; Hu S
    Sci Rep; 2019 Mar; 9(1):5381. PubMed ID: 30926889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern combined antiretroviral therapy era.
    Besson C; Lancar R; Prevot S; Algarte-Genin M; Delobel P; Bonnet F; Meyohas MC; Partisani M; Oberic L; Gabarre J; Goujard C; Boue F; Coppo P; Costello R; Hendel-Chavez H; Mekerri N; Dos Santos G; Recher C; Delarue R; Casasnovas RO; Taoufik Y; Mounier N; Costagliola D;
    AIDS; 2017 Nov; 31(18):2493-2501. PubMed ID: 28926410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival of AIDS-related diffuse large B-cell lymphoma, Burkitt lymphoma, and plasmablastic lymphoma in the German HIV Lymphoma Cohort.
    Schommers P; Hentrich M; Hoffmann C; Gillor D; Zoufaly A; Jensen B; Bogner JR; Thoden J; Wasmuth JC; Wolf T; Oette M; Müller M; Esser S; Vehreschild JJ; Fätkenheuer G; Wyen C
    Br J Haematol; 2015 Mar; 168(6):806-10. PubMed ID: 25403997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune reconstitution and risk of Kaposi sarcoma and non-Hodgkin lymphoma in HIV-infected adults.
    Jaffe HW; De Stavola BL; Carpenter LM; Porter K; Cox DR;
    AIDS; 2011 Jul; 25(11):1395-403. PubMed ID: 21572307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.